These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 278862

  • 1. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G, Valeriote F.
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [Abstract] [Full Text] [Related]

  • 2. Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemias.
    Santelli G, Valeriote F.
    Cancer Chemother Pharmacol; 1986 Sep; 18(2):101-4. PubMed ID: 3791555
    [Abstract] [Full Text] [Related]

  • 3. Schedule-dependent cytotoxicity of 5-fluorouracil in mice.
    Santelli G, Valeriote F.
    J Natl Cancer Inst; 1986 Jan; 76(1):159-64. PubMed ID: 3455738
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS, Ramonas LM.
    J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
    [Abstract] [Full Text] [Related]

  • 6. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P, Cerna I.
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.
    Fried J, Perez AG, Doblin JM, Clarkson BD.
    Cancer Res; 1981 Jul; 41(7):2627-32. PubMed ID: 7248935
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET, Vietti TJ, Valeriote FA, Coulter D.
    Anticancer Res; 1981 Jul; 1(3):149-54. PubMed ID: 7342853
    [Abstract] [Full Text] [Related]

  • 10. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
    Razek A, Vietti T, Valeriote F.
    Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
    Presant CA, Vietti T, Valeriote F.
    Cancer Res; 1975 Aug; 35(8):1926-30. PubMed ID: 50128
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.